People · Operator

Campbell Donny Murray

Named in public records as an officer, director or promoter · active 2012–2012 · Pharmaceuticals

1
Companies
1
Filings
$15.9M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Biorelix IncPharmaceuticalsSeries A$15.9M$79.2M2012
Operator network

Campbell Donny Murray at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Campbell Murray · 9 companies · 1 sharedCampbell MurrayDov Goldstein · 6 companies · 1 sharedDov GoldsteinJonathan M. Lourie · 3 companies · 1 sharedJonathan M. LourieRonald Lennox · 3 companies · 1 sharedRonald LennoxCampbell R. Murray · 2 companies · 1 sharedCampbell R. MurrayWilliam Wiesler · 2 companies · 1 sharedWilliam WieslerA. Donny Strosberg · 1 companies · 1 sharedA. Donny StrosbergBrian R. Dixon, Ph.D · 1 companies · 1 sharedBrian R. Dixon, P…Dov R. Goldstein · 1 companies · 1 sharedDov R. GoldsteinPhilipe R. Chambon · 1 companies · 1 sharedPhilipe R. ChambonPhilippe R. Chambon · 1 companies · 1 sharedPhilippe R. Chamb…Phillipe Chambon · 1 companies · 1 sharedPhillipe ChambonRonald R. Lennox · 1 companies · 1 sharedRonald R. LennoxWilliam R. Wiesler · 1 companies · 1 sharedWilliam R. WieslerBiorelix Inc · $15.9M raisedBiorelix IncCampbell Donny MurrayCM
Campbell Donny Murray Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Campbell Donny Murray on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Campbell Murray19
Dov Goldstein16
Ronald Lennox13
Jonathan M. Lourie13
Campbell R. Murray12
William Wiesler12
Philipe R. Chambon11
Philippe R. Chambon11
Phillipe Chambon11
A. Donny Strosberg11
Ronald R. Lennox11
Dov R. Goldstein11
Brian R. Dixon, Ph.D11
William R. Wiesler11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.